Number of Shares
24,994.00
Current Holdings Value*
$3.32 Mil
% of Portfolio
0.95%
Total Estimate Gain
$497,139.43
% of Total Estimate Gain
12.54%

1290 VT SmartBeta Equity ESG Portfolio's Abbott Laboratories Holding Summary

As of 2025-03-31, 1290 VT SmartBeta Equity ESG Portfolio held 24,994.00 shares of Abbott Laboratories(ABT), totaling $3.32 Mil. This investment constitutes 0.95% of their stock portfolio, and 1290 VT SmartBeta Equity ESG Portfolio now holds 0% of the outstanding Abbott Laboratories(ABT) stock.

The initial trade took place in 2019Q3. And since then 1290 VT SmartBeta Equity ESG Portfolio has made 4 purchases of ABT, at an average price of $106.77, for a total of 37,140.00 shares. In addition, there have been 2 sales at an average price of $112.92 for 12,146.00 shares. Based on historical transaction data and ABT's current price of $123.67, 1290 VT SmartBeta Equity ESG Portfolio's estimated gain on his ABT holdings is $497,139.43, reflecting a 12.54% gain to date.

1290 VT SmartBeta Equity ESG Portfolio ABT ($123.67) Holding Chart

1290 VT SmartBeta Equity ESG Portfolio ABT ($123.67) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1